{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:49:26Z","timestamp":1765295366773,"version":"3.44.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.urology.2023.01.032","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T01:55:43Z","timestamp":1675734943000},"page":"191-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Do Sodium-Glucose Co-Transporter 2 Inhibitors Increase the Risk of Urologic Implant Reintervention?"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9494-9633","authenticated-orcid":false,"given":"Zachary J.","family":"Prebay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halle","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ebbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2023.01.032_bib0001","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.esxm.2018.11.007","article-title":"Diabetes is a risk factor for inflatable penile prosthesis infection: analysis of a large statewide database","volume":"7","author":"Lipsky","year":"2019","journal-title":"Sex Med Today"},{"key":"10.1016\/j.urology.2023.01.032_bib0002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.urology.2016.06.038","article-title":"The impact of diabetes mellitus and obesity on artificial urinary sphincter outcomes in men","volume":"98","author":"Viers","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.urology.2023.01.032_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/diseases8020014","article-title":"SGLT2 inhibitors: the star in the treatment of type 2 diabetes?","volume":"8","author":"Saisho","year":"2020","journal-title":"Diseases"},{"key":"10.1016\/j.urology.2023.01.032_bib0004","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2020.1906","article-title":"Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes","volume":"323","author":"Petrie","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2023.01.032_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073651","article-title":"An overview of the cardiorenal protective mechanisms of SGLT2 inhibitors","volume":"23","author":"Salvatore","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.urology.2023.01.032_bib0006","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/dom.12244","article-title":"Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"16","author":"Monami","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.urology.2023.01.032_bib0007","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MED.0000000000000311","article-title":"An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus","volume":"24","author":"Hsia","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"suppl 1","key":"10.1016\/j.urology.2023.01.032_bib0008","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.amjcard.2019.10.029","article-title":"Safety of sodium-glucose co-transporter 2 inhibitors","volume":"124","author":"McGill","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.urology.2023.01.032_bib0009","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/20009666.2018.1527667","article-title":"Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use","volume":"8","author":"Melnick","year":"2018","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.urology.2023.01.032_bib0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1464-410X.2005.05907.x","article-title":"Outcome of penile prosthesis implantation for treating erectile dysfunction: experience with 504 procedures","volume":"97","author":"Minervini","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2023.01.032_bib0011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.12703\/r\/10-73","article-title":"Penile implant surgery-managing complications","volume":"10","author":"Cayetano-Alcaraz","year":"2021","journal-title":"Fac Rev"},{"key":"10.1016\/j.urology.2023.01.032_bib0012","unstructured":"In compare outcomes, how are patients matched when balancing cohorts? TriNetX Help Center. Available at:https:\/\/support.trinetx.com\/hc\/en-us\/articles\/360011978033-In-compare-outcomes-how-are-patients-matched-when-balancing-cohorts- Accessed December 3, 2022."},{"key":"10.1016\/j.urology.2023.01.032_bib0013","doi-asserted-by":"crossref","first-page":"e3494","DOI":"10.1002\/dmrr.3494","article-title":"Erectile dysfunction and diabetes: a melting pot of circumstances and treatments","volume":"38","author":"Defeudis","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.urology.2023.01.032_bib0014","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00210-022-02249-9","article-title":"Established and emerging treatments for diabetes-associated lower urinary tract dysfunction","volume":"395","author":"Erdogan","year":"2022","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.urology.2023.01.032_bib0015","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.21037\/tau-21-568","article-title":"Penile implant infection factors: a contemporary narrative review of literature","volume":"10","author":"Baird","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urology.2023.01.032_bib0016","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2023.01.032_bib0017","article-title":"A case of Fournier's gangrene following a large-volume hydrocelectomy in a diabetic patient managed with SGLT-2 inhibitor therapy","volume":"39","author":"Vargo","year":"2021","journal-title":"Urol Case Rep"},{"key":"10.1016\/j.urology.2023.01.032_bib0018","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/dme.13508","article-title":"Fournier's gangrene in a man on empagliflozin for treatment of Type 2 diabetes","volume":"34","author":"Kumar","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/j.urology.2023.01.032_bib0019","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M18-3136","article-title":"Sodium-glucose cotransporter-2 inhibitors and the risk for severe urinary tract infections: a population-based cohort study","volume":"171","author":"Dave","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urology.2023.01.032_bib0020","first-page":"e21720","article-title":"Frequency of urinary tract infections in type 2 diabetic patients taking dapagliflozin","volume":"14","author":"Khan","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.urology.2023.01.032_bib0021","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ckj\/sfz170","article-title":"The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?","volume":"13","author":"Sarafidis","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.urology.2023.01.032_bib0022","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.sxmr.2017.03.007","article-title":"Are urine cultures necessary prior to urologic prosthetic surgery?","volume":"6","author":"Kavoussi","year":"2018","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.urology.2023.01.032_bib0023","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jsxm.2016.10.017","article-title":"Preoperative urine culture results correlate poorly with bacteriology of urologic prosthetic device infections","volume":"14","author":"Kavoussi","year":"2017","journal-title":"J Sex Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429523000912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429523000912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:57:47Z","timestamp":1758769067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429523000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":23,"alternative-id":["S0090429523000912"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2023.01.032","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do Sodium-Glucose Co-Transporter 2 Inhibitors Increase the Risk of Urologic Implant Reintervention?","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2023.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}